Ingenito Gary's Form 4 filing
Catalyst Pharmaceuticals, Inc. (CPRX) · filed May 15, 2025
- Accession no.
- 0001161697-25-000175
- Filed
- May 15, 2025
- Trade date
- May 13-14, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $5.78M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ingenito GaryCIK 0001279473 | Officer (Chief Med. & Reg. Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 13, 2025 | Common stock, par value $0.001 per share | MOption exerciseAcquired | +200,000 | $3.42 | +$684,000 | 268,873 | Direct | |
| May 13, 2025 | Common stock, par value $0.001 per share | SSaleDisposed | −200,000 | $23.68 | −$4,736,000 | 68,873 | Direct | |
| May 14, 2025 | Common stock, par value $0.001 per share | MOption exerciseAcquired | +44,000 | $4.64 | +$204,160 | 112,873 | Direct | |
| May 14, 2025 | Common stock, par value $0.001 per share | SSaleDisposed | −44,000 | $23.63 | −$1,039,720 | 68,873 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 13, 2025 | Common Stock | MOption exerciseDisposed | −200,000 | $0.00 | $0 | 590,282 | Direct | |
| May 14, 2025 | Common Stock | MOption exerciseDisposed | −44,000 | $0.00 | $0 | 546,282 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.